2X FDA COMMISSIONER Robert Califf on AI, Vinay Prasad & Clinical Trials Ep. 1055 Dan SferaApril 24, 2026Comment
Standardizing the Chaos: Why Clinical Research Software Needs to Open Up Ep. 1053 Dan SferaApril 21, 2026Comment
From Paper CRFs to Claude on My Desktop: The Real Future of Clinical Trials Ep. 1052 Dan SferaApril 17, 2026Comment
CROs Are Obsolete (and Other Controversial Takes) in Clinical Research Ep. 1049 Dan SferaApril 7, 2026Comment
Why 2026 Is The Year Of Independent Physician Owned Micro Research Sites Ep.1048 Dan SferaApril 2, 2026Comment
The Next Billion-Dollar Clinical Research Company Will Be Built By An Operator Ep.1047 Dan SferaApril 1, 2026Comment
From Sticky Notes to AI: The Evolution of Clinical Trial Tech with Rick Greenfield Ep. 1046 Dan SferaMarch 25, 2026Comment
The $7 Billion ‘Abandoned’ Drug: Edward Van Wezel's Story From For Blood and Money Ep. 1044 Dan SferaMarch 23, 2026Comment
The Biotech Rebound is Here: But is the CRO AIpocalypse Real? Ep. 1043 Dan SferaMarch 19, 2026Comment
The 'Blacklist' Secret: Do CROs Actually Have a List of Bad Sites? Ep. 1042 Dan SferaMarch 18, 2026Comment
How to Survive an FDA Audit: Real Case Studies on PI Responsibility in Clinical Research Ep. 1039 Dan SferaMarch 10, 2026Comment
The Clinical Research Consolidation Curve: How to Value and Sell Your Site Ep. 1038 Dan SferaMarch 9, 2026Comment
The Trustless Era: How AI & Data are Changing Clinical Research Site Metrics Ep. 1036 Dan SferaFebruary 27, 2026Comment
